NCT06207539View on ClinicalTrials.gov

Induction of Abortion in the Second Trimester

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

December 1, 2022

Primary Completion Date

March 30, 2023

Study Completion Date

April 30, 2023

Conditions
Abortion, Second Trimester
Interventions
DRUG

hyoscine N-butyl bromide under the generic name of buscopan ampoule produced by Sanofi company

compare between the effects of misoprostol with hyoscine N-butyl bromide and misoprostol alone on shortening the time of abortion induction in the second trimester.

DRUG

misoprostol under the generic name of misotac tablets

compare between the effects of misoprostol with hyoscine N-butyl bromide and misoprostol alone on shortening the time of abortion induction in the second trimester.

Trial Locations (1)

Unknown

Ain Shams University, Cairo

All Listed Sponsors
lead

Ain Shams Maternity Hospital

OTHER